1P5Z | B:96-253 | STRUCTURE OF HUMAN DCK COMPLEXED WITH CYTARABINE AND ADP-MG |
1P61 | B:96-253 | STRUCTURE OF HUMAN DCK COMPLEXED WITH 2'-DEOXYCYTIDINE AND ADP, P 43 21 2 SPACE GROUP |
1P62 | B:96-253 | STRUCTURE OF HUMAN DCK COMPLEXED WITH GEMCITABINE AND ADP-MG |
2NO0 | B:96-253; B:96-253 | C4S DCK VARIANT OF DCK IN COMPLEX WITH GEMCITABINE+ADP |
2NO1 | B:96-253; B:96-253 | C4S DCK VARIANT OF DCK IN COMPLEX WITH D-DC+ADP |
2NO6 | B:96-253; B:96-253 | C4S DCK VARIANT OF DCK IN COMPLEX WITH FTC+ADP |
2NO7 | B:96-253; B:96-253 | C4S DCK VARIANT OF DCK IN COMPLEX WITH L-DC+ADP |
2NO9 | B:96-253; B:96-253 | THE STRUCTURE OF DEOXYCYTIDINE KINASE COMPLEXED WITH TROXACITABINE AND ADP. |
2QRN | D:96-253; D:96-253; D:96-253; D:96-253 | HUMAN DEOXYCYTIDINE KINASE DCMP, UDP, MG ION PRODUCT COMPLEX |
2QRO | D:96-253; D:96-253; D:96-253; D:96-253 | HUMAN DEOXYCYTIDINE KINASE DAMP, UDP, MG ION PRODUCT COMPLEX |
2ZI4 | A:96-253 | C4S DCK VARIANT OF DCK IN COMPLEX WITH L-DA+ADP |
2ZI7 | B:96-253; B:96-253 | C4S DCK VARIANT OF DCK IN COMPLEX WITH D-DG+UDP |
2ZI9 | B:96-253; B:96-253 | C4S-E247A DCK VARIANT OF DCK IN COMPLEX WITH CLADRIBINE+ADP |
2ZIA | B:96-253; B:96-253 | C4S DCK VARIANT OF DCK IN COMPLEX WITH CLADRIBINE+UDP |
3KFX | B:96-253; B:96-253 | HUMAN DCK COMPLEX WITH 5-ME DC AND ADP |
3MJR | D:96-253; D:96-253; D:96-253; D:96-253 | HUMAN DCK COMPLEX WITH ACYCLIC NUCLEOSIDE |
3QEJ | B:96-253; B:96-253 | S74E-DCK MUTANT IN COMPLEX WITH UDP |
3QEN | B:96-253; B:96-253 | S74E DCK IN COMPLEX WITH 5-BROMODEOXYCYTIDINE AND UDP |
3QEO | B:96-253; B:96-253 | S74E-R104M-D133A DCK VARIANT IN COMPLEX WITH L-DEOXYTHYMIDINE AND UDP |
2OCP | H:110-267; H:110-267; H:110-267; H:110-267; H:110-267; H:110-267; H:110-267; H:110-267 | CRYSTAL STRUCTURE OF HUMAN DEOXYGUANOSINE KINASE |